URINARY EXCRETION OF TRYPTOPHAN METABOLITES BY SCHIZOPHRENIC INDIVIDUALS
Abstract
Urine from schizophrenic patients and normal controls has been analyzed for metabolites of tryptophan, before and after oral doses of this compound. With the exception of the basal excretion of N-methyl-2-pyridone-5-carboxamide, no significant differences in the urinary excretions of tryptophan metabolites has been found.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).